Dr. Gaurav Kharya
MBBS, DCH, DNB Paediatrics, Fellowship Paediatric Haematology-Oncology & BMT
Clinical Lead, Centre for BMT & Cellular Therapy | Senior Consultant, Paediatric Haematology-Oncology & Immunology
corporate_fareApollo Hospitals, New Delhi
Gaurav Kharya
MBBS, DCH, DNB Paediatrics, Fellowship Paediatric Haematology-Oncology & BMT
Dr. Gaurav Kharya is a leading Paediatric Haematology-Oncologist and Bone Marrow Transplant specialist at Apollo Hospitals, New Delhi, where he serves as Clinical Lead of the Centre for Bone Marrow Transplant and Cellular Therapy. He brings over 26 years of experience to the care of children with blood cancers, inherited blood disorders, and immunodeficiency conditions.
Dr. Kharya's clinical work centres on haematopoietic stem cell transplantation, including haploidentical and alternative-donor protocols for children who lack a fully matched donor. His training spans Sir Ganga Ram Hospital in New Delhi, The Great North Children's Hospital in Newcastle, UK, and St Mary's Hospital at Imperial NHS Trust, London, providing an internationally grounded foundation in paediatric BMT practice. He is actively involved in cellular therapy development, CAR-T cell therapy, and advancing indigenous cell and gene therapy products in India as Founder and Director of Cellogen Therapeutics. His published research covers sickle cell disease transplantation, reduced-toxicity conditioning, and the future of paediatric cell and gene therapy in India.
CancerFax can coordinate medical record review, case preparation, and consultation support for international families seeking paediatric BMT or cellular therapy evaluation at Apollo Hospitals, New Delhi.
Why Consider Dr. Gaurav Kharya?
Dr. Kharya is one of India's leading paediatric bone marrow transplant specialists, combining advanced haploidentical transplant expertise with a focus on next-generation cellular and gene therapies for children.
Areas of Specialisation
Paediatric bone marrow transplantation, cellular immunotherapy, and complex blood and immune disorders in children
Dr. Kharya's practice focuses on children requiring bone marrow transplant, haematopoietic stem cell transplantation, cellular therapy, and advanced treatment planning for blood cancers, haemoglobinopathies, and immunodeficiency disorders.
Haematopoietic Stem Cell Transplantation
Full-spectrum paediatric BMT including matched, haploidentical, and cord blood transplant protocols for blood cancers and inherited disorders.
- arrow_rightTCR alpha-beta/CD19-depleted haploidentical transplantation
- arrow_rightTransplant planning for patients without a fully matched donor
- arrow_rightPost-transplant immunosuppression and immune reconstitution management
- arrow_rightMatched related donor (MRD) transplant
- arrow_rightMatched unrelated donor (MUD) and cord blood transplant
- arrow_rightReduced-toxicity conditioning protocols
Cellular Therapy & Immunotherapy
Advanced cellular approaches including CAR-T cell therapy and gene-therapy-oriented treatment development for eligible paediatric patients.
- arrow_rightCAR-T cell therapy for eligible paediatric blood cancer patients
- arrow_rightDevelopment of indigenous CAR-T cell therapy products in India
- arrow_rightVirus-specific T cell therapy
- arrow_rightGene-therapy-oriented approaches for haemoglobinopathies
- arrow_rightIndigenous cell and gene therapy product development through Cellogen Therapeutics
- arrow_rightClinical translation of advanced cellular therapy innovations
Paediatric Haematology-Oncology
Comprehensive management of paediatric blood cancers, inherited haematological disorders, and immunodeficiency conditions.
- arrow_rightPaediatric leukaemia — ALL and AML treatment and transplant planning
- arrow_rightPaediatric lymphoma management
- arrow_rightSolid tumours requiring BMT support
- arrow_rightThalassaemia and sickle cell disease — curative transplant approaches
- arrow_rightAplastic anaemia — transplant and immunosuppressive strategies
- arrow_rightPrimary immunodeficiency disorders — transplant planning and management
Procedures Performed
Transplant, cellular therapy, and haematology-oncology services for paediatric patients
Dr. Kharya performs a broad range of bone marrow transplant, cellular therapy, and supportive haematology-oncology procedures for children with blood cancers, inherited haematological disorders, and immunodeficiency conditions.
Bone Marrow & Stem Cell Transplantation
TransplantFull-spectrum haematopoietic stem cell transplantation including haploidentical, matched related, matched unrelated, and cord blood transplant protocols.
Cellular Therapy
Medical OncologyAdvanced cellular immunotherapy including CAR-T cell therapy and virus-specific T cell therapy for eligible paediatric patients.
Paediatric Oncology Treatment
Complex DiseaseComprehensive treatment planning for paediatric blood cancers, solid tumours, and inherited disorders requiring specialist haematology-oncology expertise.
Second Opinion & Case Review
Second OpinionStructured second-opinion consultations for paediatric blood cancers, transplant candidacy, and complex haematological conditions.
Research & Publications
Peer-reviewed contributions in paediatric BMT, haemoglobinopathies, and cellular therapy
Dr. Kharya has contributed to research on haematopoietic stem cell transplantation, sickle cell disease, thalassaemia, reduced-toxicity conditioning, and the development of indigenous cell and gene therapy in India.
Dr. Kharya is actively developing indigenous CAR-T cell and gene therapy products for paediatric patients in India through Cellogen Therapeutics and his research programme at Apollo Hospitals, New Delhi.
Education & Training
Dr. Kharya completed his medical training in India and advanced fellowships in paediatric haematology-oncology and bone marrow transplant in both India and the United Kingdom.
Clinical Experience
Dr. Kharya has built his career across leading paediatric haematology and transplant centres in India and the UK, and currently leads the Centre for Bone Marrow Transplant and Cellular Therapy at Apollo Hospitals, New Delhi.
Languages & International
Dr. Kharya consults in the following languages.
CancerFax can coordinate professional medical interpreter support for international patients consulting Dr. Kharya at Apollo Hospitals, New Delhi.
CancerFax can coordinate professional medical interpreter support for international families when required.
How CancerFax Helps You Access Dr. Gaurav Kharya
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Gaurav Kharya's team — with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history — prepared as a structured clinical summary for Dr. Gaurav Kharya's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Gaurav Kharya before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Gaurav Kharya's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Gaurav Kharya's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Gaurav Kharya's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Dr. Gaurav Kharya
Dr. Gaurav Kharya specialises in Paediatric Haematology-Oncology, Bone Marrow Transplant, Cellular Therapy, and Immunology. His practice includes bone marrow transplant for children with blood cancers, thalassaemia, sickle cell disease, aplastic anaemia, and primary immunodeficiency disorders, as well as CAR-T cell therapy and cell and gene therapy development.
Dr. Gaurav Kharya is Clinical Lead of the Centre for Bone Marrow Transplant and Cellular Therapy at Apollo Hospitals (Indraprastha Apollo Hospital), New Delhi. He also serves as Senior Consultant in Paediatric Haematology-Oncology and Immunology at the same institution.
CancerFax can coordinate medical record review, case preparation, and consultation support for international families seeking evaluation or bone marrow transplant planning with Dr. Kharya at Apollo Hospitals, New Delhi, subject to hospital availability and case acceptance.
Yes. Haploidentical transplantation is central to Dr. Kharya's practice. He uses protocols including TCR alpha-beta/CD19-depleted haploidentical transplant, which enables curative therapy for children without a fully matched related or unrelated donor — including cases of thalassaemia, sickle cell disease, leukaemia, and immunodeficiency disorders.
Dr. Kharya is actively involved in CAR-T cell therapy and the development of indigenous cell and gene therapy products in India through Cellogen Therapeutics and his programme at Apollo Hospitals, New Delhi. Eligibility for specific CAR-T therapies depends on diagnosis and current programme status. CancerFax can help assess suitability and coordinate the consultation process.
A second-opinion request for a paediatric blood cancer, bone marrow transplant candidacy, or complex haematological condition can be submitted through CancerFax with pathology reports, imaging, treatment history, and relevant test results. The consultation format and availability depend on the doctor's schedule and institutional guidelines.
Connect with Gaurav Kharya Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.